湖北亨迪藥業股份有限公司(301211.SZ) 始創于1995年，是中國領先的CDMO服務企業和特色原料藥生產企業，荊門和武漢兩個基地共十二次通過歐美官方檢查認證，客戶遍及全世界90多個國家和地區。30年來向全球跨國藥企和新藥研創公司提供CDMO/CMO服務，提供原料藥從新藥臨床前藥學研究、各階段臨床到商業化生產的一站式服務。總反應能力約1000立方，涵蓋多個OEB4-5高活性GMP生產線，反應釜體積5L~5000L，能承接從克、公斤、噸、百噸、千噸等不同規模的小分子原料藥及中間體的合同研發與生產業務。

Hubei Heilen Pharmaceutical Co., Ltd. (stock code: 301211. SZ), established in 1995, is a leading enterprise of CDMO service and generic API production in China. Jingmen and Wuhan sites were approved by EU & US official inspection for 12 times, supporting global customers in more than 90 countries and regions. During past 30 years, we have provided CDMO/CMO services to global pharmaceutical companies and new drug R&D companies. We are able to provide one-stop API services for global clients, including preclinical pharmaceutical research for new drugs, research and development and production of API at clinical and various stages, and commercial production. The total reaction capacity is about 1000M³, covering multiple OEB4-5 Highly Potent API GMP production lines, with a reactor volume of 5L~5000L. It can undertake CDMO/CMO business of small molecule APIs and intermediates of different scales from grams/kilos to thousands of tons.